AHSCT RUSSIA
General Information
Stages of Treatment
Advantages of Program
Eligibility Criteria
Application for Treatment
Preparation for Treatment
Pre-Transplant Examination
Admission to the Hospital
Follow-Up After HSCT
Webinar with Dr.Fedorenko
International Conference
About us
Language Menu ⇨
Site Map
© All Right Reserved. AHSCT RUSSIA, Moscow 2020.
⇦ Main Menu
Arabic
English
Deutsch
Nederlands
Français
Italiano
Norsk
Español
Serbian
Application
Admission
SiteMap
Language Menu ⇨
Approach
Advantages
Eligibility Criteria
Preparation
Examination
Treatment
Follow Up
Webinar
Conference
About us
Application
Admission
SiteMap
December 21st, 2025 21:00
(GMT+3)
Online Consultation
about HSCT treatment with
Dr.Fedorenko
Days
Hours
Minutes
Seconds
Leave your Name and Email to join
Done
Check what time it will be in your location - (24TimeZones.com)
Washington, Ottawa
USA, Canada
21.12.2025 - 13:00
United Kingdom, Ireland
21.12.2025 - 18:00
Austria, Belgium, Croatia, Czechia, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland.
Europe
21.12.2025 - 19:00
Bulgaria, Romania
21.12.2025 - 20:00
Russia, Saudi Arabia, Turkey
21.12.2025 - 21:00
Canberra
Australia
22.12.2025 - 05:00
New Zealand
22.12.2025 - 07:00
A list of underlying medical conditions for HSCT treatment of autoimmune diseases
Webinar records with PhD, MD, Dr. Denis Fedorenko
Intermediate-Intensity Chemotherapy (IDCT) + AHSCT for patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
Indications and Efficacy of Disease-Modifying Therapies and Supportive Care of Multiple Sclerosis
Research Article: Acta Scientific Neurology (ASNE) Volume 8 Issue 11 November 2025
Comparison of HSCT treatment protocols available to foreign citizens